KR950007801A - Medical devices prone to disintegration - Google Patents

Medical devices prone to disintegration Download PDF

Info

Publication number
KR950007801A
KR950007801A KR1019940024420A KR19940024420A KR950007801A KR 950007801 A KR950007801 A KR 950007801A KR 1019940024420 A KR1019940024420 A KR 1019940024420A KR 19940024420 A KR19940024420 A KR 19940024420A KR 950007801 A KR950007801 A KR 950007801A
Authority
KR
South Korea
Prior art keywords
medical device
ion
group
polymer
crosslinked polymer
Prior art date
Application number
KR1019940024420A
Other languages
Korean (ko)
Inventor
앤드류 루지오 게리
앤토니 톰슨 사무엘
Original Assignee
스티븐 에이치. 마르코위츠
헤르큘레스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스티븐 에이치. 마르코위츠, 헤르큘레스 인코포레이티드 filed Critical 스티븐 에이치. 마르코위츠
Publication of KR950007801A publication Critical patent/KR950007801A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/148Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]
    • Y10T428/2985Solid-walled microcapsule from synthetic polymer
    • Y10T428/2987Addition polymer from unsaturated monomers only

Abstract

The present invention provides medical devices comprised of ionically crosslinked polymer, especially, stents, catheter or cannula components, plugs, and constrictors. The medical devices of the present invention are prepared by treatment of ionically crosslinkable polymer compositions with crosslinking ion compositions to provide ionically crosslinked materials. An important aspect of the present invention is that these medical devices can be disintegrated in-vivo at a desired time through the exposure of the medical device to a chemical trigger which generally is described as an agent that acts to displace the crosslinking ion in the ionically crosslinked material through binding or simple replacement with a non-crosslinking ion.

Description

붕해가 촉발되기 쉬운 의료 장치물Medical devices prone to disintegration

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (26)

스텐트, 카테터 또는 캐뉼라 구성요소, 플러그 및 수축기로 이루어진 그룹중에서 선택된 하나이상의 부재, 및 이온 가교결합된 중합체를 포함하는 의료 장치.A medical device comprising at least one member selected from the group consisting of stents, catheter or cannula components, plugs and constrictors, and ion crosslinked polymers. 제1항에 있어서, 상기 이온 가교결합된 중합체가 카복실, 설페이트 및 아민 작용화된 중합체들로 이루어진 그룹중에서 선택된 하나이상의 이온 가교결합성 중합체로 부터 제조된 하나이상의 중합체를 포함하는 의료 장치.The medical device of claim 1, wherein the ion crosslinked polymer comprises one or more polymers made from one or more ion crosslinkable polymers selected from the group consisting of carboxyl, sulfate and amine functionalized polymers. 제1항에 있어서, 상기 이온 가교결합된 중합체가 하나이상의 폴리사카러이드르 부터 제조된 하나이상의 중합체를 포함하는 의료 장치.The medical device of claim 1, wherein the ion crosslinked polymer comprises one or more polymers made from one or more polysaccharides. 제1항에 있어서, 상기 이온 가교결합된 중합체가 하나이상의 이온 가교결합성 음이온 중합체로 부터 제조된 하나이상의 중합체를 포함하는 의료 장치.The medical device of claim 1, wherein the ion crosslinked polymer comprises one or more polymers made from one or more ion crosslinkable anionic polymers. 제1항에 있어서, 상기 이온 가교결합된 중합체가 하나이상의 이온 가교결합성 양이온 중합체로 부터 제조된 하나이상의 중합체를 포함하는 의료 장치.The medical device of claim 1, wherein the ion crosslinked polymer comprises one or more polymers made from one or more ion crosslinkable cationic polymers. 제4항에 있어서, 상기 이온 가교결합된 음이온 중합체가 폴리아크릴산, 폴리데타크릴산, 알긴산, 펙턴산, 카복시 메틸 셀룰로즈, 하아루론산, 헤파린, 카복시메틸 전분, 카복시메틸 텍스트란, 해파린 설페이트 및 콘드로 이틴 설페이트, 및 이들의 염들로 이루어진 그룹중에서 선택된 하나이상의 이온 가교결합성 중합체로 부터 제조된 하나이상의 중합체를 포함하는 의료 장치.The method of claim 4, wherein the ion crosslinked anionic polymer is selected from the group consisting of polyacrylic acid, polydeacrylic acid, alginic acid, pectonic acid, carboxymethyl cellulose, haaruronic acid, heparin, carboxymethyl starch, carboxymethyl textane, heparin sulfate and A medical device comprising at least one polymer prepared from at least one ion crosslinkable polymer selected from the group consisting of chondroitin sulfate, and salts thereof. 제5항에 있어서, 상기 이온 가교결합된 양이온 중합체가 키토산, 양이온성 구아, 양이온성 전분 및 폴리에틸렌 아민으로 이루어진 그룹중에서 선택된 하나이상이 이온 가교결합성 중합체로 부터 제조된 하나이상의 중합체를 포함하는 의료 장치.6. The medical treatment of claim 5 wherein the ionic crosslinked cationic polymer comprises at least one polymer selected from the group consisting of chitosan, cationic guar, cationic starch and polyethylene amine comprising at least one polymer prepared from ionic crosslinkable polymers. Device. 제1항에 있어서, 상기 이온 가교결합된 중합체가 하나이상의 양이온을 포함하고 가교결합 이온에 해 가교결합된 의료 장치.The medical device of claim 1, wherein the ion crosslinked polymer comprises one or more cations and crosslinked by crosslinking ions. 제8항에 있어서, 상기 하나이상의 양이온이 칼슘, 마그네슘, 바륨, 스트론륨, 숭소, 배틸륨, 알루미늄, 철, 구리, 코발트, 납 및 은 이온들로 이루어진 그룹중에서 선택된 의료 장치.The medical device of claim 8, wherein the at least one cation is selected from the group consisting of calcium, magnesium, barium, strontium, saxophonium, batilium, aluminum, iron, copper, cobalt, lead and silver ions. 제1항에 있어서, 상기 이온 가교결합된 중합체가 하나이상의 음이온을 포함하는 가교결합 이온에 의해 가교결합된 의료 장치.The medical device of claim 1, wherein the ion crosslinked polymer is crosslinked by crosslinking ions comprising one or more anions. 제10항에 있어서, 상기 하나이상의 음이온이 포스페이트, 시트레이트, 보레이트, 속시네이트, 말리에이트, 아디페이트 및 옥살레이트 이온들로 이루어진 그룹중에서 선택된 의료 장치.The medical device of claim 10, wherein the at least one anion is selected from the group consisting of phosphate, citrate, borate, soxate, maleate, adipate and oxalate ions. 제1항 내지 11항중 어느 한 항에 있어서, 뇨, 담즙, 변 및 장액으로 이루어진 그 그룹중에서 선택된 하나이상의 체액을 또한 포함하는 의료 장치.The medical device of claim 1, further comprising one or more body fluids selected from the group consisting of urine, bile, stool, and serous fluid. 제1항 내지 11항중 어느 한 항에 있어서, 가교결합 이온을 치환시키는 시약을 또한 포함하는 의료 장치.The medical device of claim 1, further comprising a reagent to substitute crosslinking ions. 제13항에 있어서, 상기 가교결합 이온을 치환시키는 시약이 에틸렌 디아민 테트라 아세트산, 에틸렌 디아민 테트라아세테이트, 시트레이트, 유기 포스페이트, 무기 포스페어트. 트리나트륨 카복시메틸옥시숙시네이트, 니트릴로트리아세트산, 말레산, 옥살레이트, 폴리아크릴산, 나트륨, 칼륨, 칼슘 및 마그네슘으로 이루어진 그룹 중에서 선택된 하나이상의 구성원들을 포함하는 의료 장치.The method of claim 13, wherein the reagent for replacing the crosslinking ions is ethylene diamine tetra acetic acid, ethylene diamine tetraacetate, citrate, organic phosphate, inorganic phosphate. A medical device comprising at least one member selected from the group consisting of trisodium carboxymethyloxysuccinate, nitrilotriacetic acid, maleic acid, oxalate, polyacrylic acid, sodium, potassium, calcium and magnesium. 제14항에 있어서, 상기 무기 포스페이트가 펜타나트륨 트리폴리포스페이트, 일-및 이열기성 인산 칼륨, 나트륩 프로포스페이트 및 인산으로 이루어진 그룹중에서 선택된 의료 장치.15. The medical device of claim 14, wherein the inorganic phosphate is selected from the group consisting of pentasodium tripolyphosphate, mono- and dipyritic potassium phosphate, nat prop propphosphate and phosphoric acid. 생체내 의료 장치를 하나이상의 화학적 촉발제(chemical trigger)로 처리함을 포함하는 상기 생체내 의료장치의 용해 방법.Dissolving the in vivo medical device with at least one chemical trigger. 제16항에 있어서, 상기 생체내 의료 장치가 이은 가교결합된 중합체를 포함하고, 상기 화학적 촉발제가 가교결합 이온을 치환시키는 하나 이상의 시약을 포함하는 방법.The method of claim 16, wherein the in vivo medical device comprises a crosslinked polymer followed by the chemical trigger comprising one or more reagents to replace the crosslinking ions. 제1항 내지 15하중 어느 한 항의 의료 장치를 인간 및 동물에게 도입시킴을 포함하는, 상기 인간 및 동물의 의학적 치료 방법.A method of medical treatment of humans and animals comprising introducing a medical device of any one of claims 1 to 15 into humans and animals. 이온 가교결합성 중합체를 가교결합 이온으로 처리하므로써 상기 중합체를 가교결합시켜서 스텐트, 카테티 또는 캐뉼라 구성요소, 플러그 및 수축기로 이루어진 그룹중에서 선택되는 하나이상의 부재와 상기 이온 가교결합된 중합체를 포함하는 의료 장치를 제조하여 인간 및 동물에게 도입시킴을 포함하는, 상기 인간 및, 동물의의학적 치료 방법.Medically comprising the ion crosslinked polymer with one or more members selected from the group consisting of stents, catheters or cannula components, plugs and shrinkages by crosslinking the polymer by treating the ion crosslinkable polymer with crosslinking ions. A method of medical treatment of humans and animals comprising the manufacture of a device and introduction into humans and animals. 제18항 또는 19항에 있어서, 상기 의료 장치를 화학적 촉발재로 붕해시키는 단계를 또한 포함하는 방법.20. The method of claim 18 or 19, further comprising disintegrating the medical device with a chemical trigger. 제20항에 있어서, 상기 화학적 촉발제가 가교격합 이온을 치환시키는 하나이상의 시약을 포함하는 방법.21. The method of claim 20, wherein said chemical trigger comprises one or more reagents to replace cross-linking ions. 90% 미만의 수함량을 갖는 이온 가교결합된 중합체 하이드로겔을 포함하는 의료 장치.A medical device comprising an ionic crosslinked polymer hydrogel having a water content of less than 90%. 이온 가교결합된 중합체를 포함하는 의료 장치를 약 40℃ 이상의 온도에서 가열함을 포함하는 상기 의료장치의 변형 방법.And modifying the medical device comprising the ion crosslinked polymer at a temperature of about 40 ° C. or greater. 이온 가교결합성 중합체를 다이를 통해 도입시켜 튜브를 성형시키고, 동시에 상기 성형된 튜브를 통해 가교결합 이온을 포함하는 용액을 펌펑시키고, 상기 성형된 튜브를 상기 다이로 부터 가교결합 이온을 포함하는 용액내로 압출시킨 다음, 임의로 상기 성형된 튜브를 열처리함을 포함하는 튜브형 제품의 제조 방법.Introducing an ion crosslinkable polymer through a die to shape a tube, simultaneously pumping a solution comprising crosslinking ions through the shaped tube, and solution forming the tube containing crosslinking ions from the die Extruding into and then optionally heat treating the shaped tube. 위장관, 비뇨생식기, 심혈관, 림프관, 이인후, 안, 신경, 외피 및 근육계로 이루어진 그룹중에서 선택된 인간 또는 동물계에서의 이온 가교결합된 중합체를 포함하는 의료 장치의 용도.Use of a medical device comprising an ionic crosslinked polymer in a human or animal system selected from the group consisting of gastrointestinal tract, genitourinary, cardiovascular, lymphatic, otolaryngological, ocular, nerve, cortical and muscular systems. 121℃ 이상의 온도에서 살균할수 있는, 이온 가교결합된 중합체를 포함하는 의료 장치.A medical device comprising an ion crosslinked polymer that can be sterilized at a temperature of 121 ° C. or higher. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019940024420A 1993-09-29 1994-09-28 Medical devices prone to disintegration KR950007801A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/128,952 US5531716A (en) 1993-09-29 1993-09-29 Medical devices subject to triggered disintegration
US08/128,952 1993-09-29

Publications (1)

Publication Number Publication Date
KR950007801A true KR950007801A (en) 1995-04-15

Family

ID=22437777

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940024420A KR950007801A (en) 1993-09-29 1994-09-28 Medical devices prone to disintegration

Country Status (13)

Country Link
US (5) US5531716A (en)
EP (1) EP0645150B1 (en)
JP (1) JP3703155B2 (en)
KR (1) KR950007801A (en)
CN (1) CN1114177A (en)
AT (1) ATE209511T1 (en)
AU (1) AU685152B2 (en)
BR (1) BR9403911A (en)
CA (1) CA2132293C (en)
DE (1) DE69429227T2 (en)
DK (1) DK0645150T3 (en)
PL (1) PL177431B1 (en)
RU (1) RU2138297C1 (en)

Families Citing this family (196)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5531716A (en) * 1993-09-29 1996-07-02 Hercules Incorporated Medical devices subject to triggered disintegration
US6361526B1 (en) 1993-11-01 2002-03-26 Medtronic Xomed, Inc. Antimicrobial tympanostomy tube
US5505713A (en) * 1994-04-01 1996-04-09 Minimed Inc. Indwelling catheter with stable enzyme coating
US5931165A (en) * 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
US5531735A (en) * 1994-09-27 1996-07-02 Hercules Incorporated Medical devices containing triggerable disintegration agents
US6214331B1 (en) * 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
US7896914B2 (en) * 1995-06-07 2011-03-01 Cook Incorporated Coated implantable medical device
US7846202B2 (en) * 1995-06-07 2010-12-07 Cook Incorporated Coated implantable medical device
US7550005B2 (en) 1995-06-07 2009-06-23 Cook Incorporated Coated implantable medical device
US7611533B2 (en) 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US20070203520A1 (en) * 1995-06-07 2007-08-30 Dennis Griffin Endovascular filter
US7867275B2 (en) * 1995-06-07 2011-01-11 Cook Incorporated Coated implantable medical device method
US5702682A (en) * 1995-12-01 1997-12-30 Hercules Incorporated Methods for preparing radiopaque medical devices
US5684051A (en) * 1996-04-24 1997-11-04 Hercules Incorporated Medical devices with improved elastic response
US5718862A (en) * 1996-04-24 1998-02-17 Hercules Incorporated Secondary shaping of ionically crosslinked polymer compositions for medical devices
DE69734060T2 (en) 1996-05-24 2006-06-29 Angiotech Pharmaceuticals, Inc., Vancouver PREPARATIONS AND METHODS FOR TREATING OR PREVENTING DISEASES OF THE BODY PASSAGE PATHS
WO1997046177A1 (en) * 1996-05-31 1997-12-11 The University Of Western Ontario Expansible bioprosthetic valve stent
US5791352A (en) * 1996-06-19 1998-08-11 Fusion Medical Technologies, Inc. Methods and compositions for inhibiting tissue adhesion
US6060534A (en) 1996-07-11 2000-05-09 Scimed Life Systems, Inc. Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
US6368356B1 (en) 1996-07-11 2002-04-09 Scimed Life Systems, Inc. Medical devices comprising hydrogel polymers having improved mechanical properties
US5820918A (en) * 1996-07-11 1998-10-13 Hercules Incorporated Medical devices containing in-situ generated medical compounds
US6530951B1 (en) * 1996-10-24 2003-03-11 Cook Incorporated Silver implantable medical device
DE59608936D1 (en) * 1996-12-04 2002-04-25 Erbe Elektromedizin ARTIFICIAL FABRIC
EP1763284B1 (en) * 1997-07-18 2018-06-13 Resound Corporation Behind the ear hearing system
WO1999004601A1 (en) * 1997-07-18 1999-01-28 Resound Corporation Behind the ear hearing aid system
US6186985B1 (en) 1997-10-03 2001-02-13 Boston Scientific Corporation Gastro-intestinal tube with dissolvable support bolster
US6293960B1 (en) 1998-05-22 2001-09-25 Micrus Corporation Catheter with shape memory polymer distal tip for deployment of therapeutic devices
US7314477B1 (en) 1998-09-25 2008-01-01 C.R. Bard Inc. Removable embolus blood clot filter and filter delivery unit
US6356782B1 (en) * 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US9669113B1 (en) 1998-12-24 2017-06-06 Devicor Medical Products, Inc. Device and method for safe location and marking of a biopsy cavity
US6371904B1 (en) 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6165140A (en) 1998-12-28 2000-12-26 Micrus Corporation Composite guidewire
DK173680B1 (en) 1999-02-10 2001-06-11 Coloplast As ostomy Prop
WO2000050103A1 (en) * 1999-02-25 2000-08-31 Scimed Life Systems, Inc. Medical devices comprising hydrogel polymers having improved mechanical properties
US6575930B1 (en) * 1999-03-12 2003-06-10 Medrad, Inc. Agitation devices and dispensing systems incorporating such agitation devices
US6231589B1 (en) 1999-03-22 2001-05-15 Microvena Corporation Body vessel filter
US6352531B1 (en) 1999-03-24 2002-03-05 Micrus Corporation Variable stiffness optical fiber shaft
US6887235B2 (en) 1999-03-24 2005-05-03 Micrus Corporation Variable stiffness heating catheter
CA2685349C (en) 1999-11-15 2013-09-17 Bio Syntech Canada Inc. Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
ATE247495T1 (en) * 1999-12-09 2003-09-15 Biosyntech Canada Inc MINERAL-POLYMER HYBRID COMPOSITION
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
US6592566B2 (en) 2000-02-03 2003-07-15 Arizona Board Of Regents Method for forming an endovascular occlusion
IL153490A0 (en) 2000-06-29 2003-07-06 Biosyntech Canada Inc Composition and method for the repair and regeneration of cartilage and other tissues
US6607553B1 (en) 2000-11-17 2003-08-19 B. Braun Medical, Inc. Method for deploying a thermo-mechanically expandable stent
US6913765B2 (en) * 2001-03-21 2005-07-05 Scimed Life Systems, Inc. Controlling resorption of bioresorbable medical implant material
DE10115740A1 (en) * 2001-03-26 2002-10-02 Ulrich Speck Preparation for restenosis prophylaxis
WO2002103004A1 (en) * 2001-06-15 2002-12-27 The Children's Hospital Of Philadelphia Surface modification for improving biocompatibility
US20040143180A1 (en) * 2001-11-27 2004-07-22 Sheng-Ping Zhong Medical devices visible under magnetic resonance imaging
US20030100830A1 (en) * 2001-11-27 2003-05-29 Sheng-Ping Zhong Implantable or insertable medical devices visible under magnetic resonance imaging
US20030153971A1 (en) * 2002-02-14 2003-08-14 Chandru Chandrasekaran Metal reinforced biodegradable intraluminal stents
US20030153972A1 (en) * 2002-02-14 2003-08-14 Michael Helmus Biodegradable implantable or insertable medical devices with controlled change of physical properties leading to biomechanical compatibility
US9204956B2 (en) 2002-02-20 2015-12-08 C. R. Bard, Inc. IVC filter with translating hooks
US8328877B2 (en) 2002-03-19 2012-12-11 Boston Scientific Scimed, Inc. Stent retention element and related methods
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
GB0210216D0 (en) * 2002-05-03 2002-06-12 First Water Ltd Ionically crosslinked alginate hydrogels, process for their manufacture and their use in medical devices
WO2003105917A2 (en) 2002-06-12 2003-12-24 Scimed Life Systems, Inc. Bulking agents
DK1521603T3 (en) 2002-07-12 2011-04-18 Cook Inc Coated medical device
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7338433B2 (en) 2002-08-13 2008-03-04 Allergan, Inc. Remotely adjustable gastric banding method
EP1553878B1 (en) 2002-08-28 2010-02-24 Allergan, Inc. Fatigue-resistant gastric banding device
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
DE10243132B4 (en) 2002-09-17 2006-09-14 Biocer Entwicklungs Gmbh Anti-infective, biocompatible titanium oxide coatings for implants and methods of making them
DE10244847A1 (en) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medical device for drug delivery
AU2003278987A1 (en) * 2002-09-26 2004-04-19 The Children's Hospital Of Philadelphia Method of determining surface binding capacity
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US6992127B2 (en) 2002-11-25 2006-01-31 Ast Products, Inc. Polymeric coatings containing a pH buffer agent
US8709038B2 (en) * 2002-12-20 2014-04-29 Boston Scientific Scimed, Inc. Puncture hole sealing device
EP1610752B1 (en) * 2003-01-31 2013-01-02 Boston Scientific Limited Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same
FR2861734B1 (en) * 2003-04-10 2006-04-14 Corneal Ind CROSSLINKING OF LOW AND HIGH MOLECULAR MASS POLYSACCHARIDES; PREPARATION OF INJECTABLE SINGLE PHASE HYDROGELS; POLYSACCHARIDES AND HYDROGELS OBTAINED
US6923996B2 (en) * 2003-05-06 2005-08-02 Scimed Life Systems, Inc. Processes for producing polymer coatings for release of therapeutic agent
WO2004100282A2 (en) * 2003-05-12 2004-11-18 Cambridge University Technical Services Limited Manufacture of a polymer device
GB0310858D0 (en) * 2003-05-12 2003-06-18 Univ Cambridge Tech Polymer transistor
US7364585B2 (en) * 2003-08-11 2008-04-29 Boston Scientific Scimed, Inc. Medical devices comprising drug-loaded capsules for localized drug delivery
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
WO2005037062A2 (en) 2003-10-14 2005-04-28 Pluromed, Inc. Confinement of kidney-stone fragments during lithotripsy
US7294123B2 (en) * 2003-12-17 2007-11-13 Corris Neurovascular, Inc. Activatable bioactive vascular occlusive device and method of use
US7790193B2 (en) * 2003-12-23 2010-09-07 Fmc Biopolymer As Use of alginate matrices to control cell growth
KR101291439B1 (en) 2004-01-23 2013-07-31 알러간, 인코포레이티드 Releasably-securale one-piece adjustable gastric band
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US20050220882A1 (en) * 2004-03-04 2005-10-06 Wilson Pritchard Materials for medical implants and occlusive devices
BRPI0508527A (en) 2004-03-08 2007-08-14 Endoart Sa tubular system closure system
EP1732635B1 (en) 2004-03-18 2011-07-27 Allergan, Inc. Apparatus for volume adjustment of intragastric balloons
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US7704267B2 (en) 2004-08-04 2010-04-27 C. R. Bard, Inc. Non-entangling vena cava filter
MX2007004261A (en) * 2004-10-12 2007-06-18 Fmc Biopolymer As Self-gelling alginate systems and uses thereof.
US7794473B2 (en) 2004-11-12 2010-09-14 C.R. Bard, Inc. Filter delivery system
US8425550B2 (en) 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US8267954B2 (en) 2005-02-04 2012-09-18 C. R. Bard, Inc. Vascular filter with sensing capability
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US8251888B2 (en) 2005-04-13 2012-08-28 Mitchell Steven Roslin Artificial gastric valve
WO2006116383A2 (en) 2005-04-25 2006-11-02 Ev3, Inc. Controlled fracture connections for stents
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
BRPI0611278A2 (en) 2005-05-02 2010-08-31 Gen Hospital Corp lithiasis treatment without lithotripsy
CA2607580C (en) 2005-05-12 2016-12-20 C.R. Bard Inc. Removable embolus blood clot filter
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
CA2616818C (en) 2005-08-09 2014-08-05 C.R. Bard, Inc. Embolus blood clot filter and delivery system
US8007509B2 (en) 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
CA2628313A1 (en) * 2005-11-04 2007-05-31 Bio Syntech Canada Inc. Composition and method for efficient delivery of nucleic acids to cells using chitosan
US9131999B2 (en) 2005-11-18 2015-09-15 C.R. Bard Inc. Vena cava filter with filament
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US8152839B2 (en) 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US8043206B2 (en) 2006-01-04 2011-10-25 Allergan, Inc. Self-regulating gastric band with pressure data processing
US7798954B2 (en) * 2006-01-04 2010-09-21 Allergan, Inc. Hydraulic gastric band with collapsible reservoir
US20070191878A1 (en) * 2006-01-20 2007-08-16 Segner Garland L Body vessel filter
US8828077B2 (en) * 2006-03-15 2014-09-09 Medinol Ltd. Flat process of preparing drug eluting stents
WO2007133366A2 (en) 2006-05-02 2007-11-22 C. R. Bard, Inc. Vena cava filter formed from a sheet
US9326842B2 (en) 2006-06-05 2016-05-03 C. R . Bard, Inc. Embolus blood clot filter utilizable with a single delivery system or a single retrieval system in one of a femoral or jugular access
JP5248492B2 (en) * 2006-07-14 2013-07-31 エフエムシー バイオポリマー エイエス Hydrogels containing low molecular weight alginate and biostructures made therefrom
JP5216596B2 (en) * 2006-10-26 2013-06-19 千寿製薬株式会社 Ophthalmic aqueous solution
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
JP5805369B2 (en) * 2007-03-20 2015-11-04 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Urological medical devices for releasing therapeutic agents
JP2010522023A (en) * 2007-03-20 2010-07-01 ボストン サイエンティフィック サイムド,インコーポレイテッド Urological medical device for releasing beneficial therapeutics to the prostate
US20080243234A1 (en) * 2007-03-27 2008-10-02 Medtronic Vascular, Inc. Magnesium Alloy Stent
BRPI0811784A2 (en) * 2007-05-23 2011-05-10 Allergan Inc cross-linked collagen and use thereof
WO2008157285A1 (en) 2007-06-13 2008-12-24 Fmc Corporation Biopolymer based implantable degradable devices
US20110077737A1 (en) * 2007-07-30 2011-03-31 Allergan, Inc. Tunably Crosslinked Polysaccharide Compositions
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
CN101918007B (en) * 2007-08-28 2014-06-04 Fmc有限公司 Delayed self-gelling alginate systems and uses thereof
US8697044B2 (en) * 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
DE102007050839A1 (en) * 2007-10-24 2009-04-30 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Carbohydrate-based additives with adhesive effect for aqueous fire and fire protection agents, their preparation and use
EP2207424B1 (en) 2007-11-16 2014-06-04 Allergan, Inc. Compositions and methods for treating purpura
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8241657B2 (en) 2007-12-04 2012-08-14 Boston Scientific Scimed, Inc. Biodisintegrable medical devices
US8668863B2 (en) * 2008-02-26 2014-03-11 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
US20090263458A1 (en) * 2008-04-21 2009-10-22 Lasse Daniel Efskind Material for surgical use in traumatology
CN102065849B (en) 2008-04-24 2015-04-29 麦德托尼克公司 Protective gel based on chitosan and oxidized polysaccharide
AU2009240513B2 (en) 2008-04-24 2015-03-26 Medtronic, Inc. Chitosan-containing protective composition
EP2291524A2 (en) 2008-04-24 2011-03-09 Medtronic, Inc Rehydratable thiolated polysaccharide particles and sponge
JP5738753B2 (en) 2008-04-24 2015-06-24 メドトロニック,インコーポレイテッド Rehydratable polysaccharide particles and sponges
US8357795B2 (en) * 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
ES2829971T3 (en) 2008-09-02 2021-06-02 Tautona Group Lp Hyaluronic acid threads and / or derivatives thereof, methods to manufacture them and uses thereof
GB0816365D0 (en) * 2008-09-08 2008-10-15 Univ Belfast Polymeric material
WO2010042493A1 (en) 2008-10-06 2010-04-15 Allergan, Inc. Mechanical gastric band with cushions
US20100305397A1 (en) * 2008-10-06 2010-12-02 Allergan Medical Sarl Hydraulic-mechanical gastric band
US20100185049A1 (en) 2008-10-22 2010-07-22 Allergan, Inc. Dome and screw valves for remotely adjustable gastric banding systems
JP5685253B2 (en) 2009-07-29 2015-03-18 シー・アール・バード・インコーポレーテッドC R Bard Incorporated Tubular filter
CN102695500A (en) 2009-11-09 2012-09-26 聚光灯技术合伙有限责任公司 Polysaccharide based hydrogels
AU2010314994B2 (en) 2009-11-09 2016-10-06 Spotlight Technology Partners Llc Fragmented hydrogels
US10240419B2 (en) 2009-12-08 2019-03-26 Baker Hughes, A Ge Company, Llc Downhole flow inhibition tool and method of unplugging a seat
EP2338477A1 (en) 2009-12-15 2011-06-29 bene-Arzneimittel GmbH Suppository comprising pantoprazole
US20110172180A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US20110171286A1 (en) * 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US8758221B2 (en) 2010-02-24 2014-06-24 Apollo Endosurgery, Inc. Source reservoir with potential energy for remotely adjustable gastric banding system
US8840541B2 (en) * 2010-02-25 2014-09-23 Apollo Endosurgery, Inc. Pressure sensing gastric banding system
RU2440808C2 (en) * 2010-02-27 2012-01-27 Учреждение Российской академии наук Институт органического синтеза им. И.Я. Постовского Уральского отделения РАН Adhesive composition for detachable dentures
EP2544652A2 (en) * 2010-03-12 2013-01-16 Allergan Industrie SAS A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition.
DK2550027T4 (en) 2010-03-22 2019-05-13 Allergan Inc CROSS-BAND POLYSACCHARID AND PROTEIN POLYSACCHARID HYDROCHLORIC PRODUCTS
AR081808A1 (en) * 2010-03-26 2012-10-24 Philip Morris Prod PROCEDURE TO PRODUCE A CONTINUOUS STRUCTURE OF AN ENCAPSULATED MATERIAL
US20110270024A1 (en) 2010-04-29 2011-11-03 Allergan, Inc. Self-adjusting gastric band having various compliant components
US9028394B2 (en) 2010-04-29 2015-05-12 Apollo Endosurgery, Inc. Self-adjusting mechanical gastric band
US9044298B2 (en) 2010-04-29 2015-06-02 Apollo Endosurgery, Inc. Self-adjusting gastric band
US20110270025A1 (en) 2010-04-30 2011-11-03 Allergan, Inc. Remotely powered remotely adjustable gastric band system
US8517915B2 (en) 2010-06-10 2013-08-27 Allergan, Inc. Remotely adjustable gastric banding system
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US20120059216A1 (en) 2010-09-07 2012-03-08 Allergan, Inc. Remotely adjustable gastric banding system
EP2624874A4 (en) 2010-10-08 2014-04-02 Univ Texas Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
WO2012048283A1 (en) 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System One-step processing of hydrogels for mechanically robust and chemically desired features
US8961393B2 (en) 2010-11-15 2015-02-24 Apollo Endosurgery, Inc. Gastric band devices and drive systems
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
EP2714002B1 (en) 2011-06-03 2019-04-03 Allergan, Inc. Dermal filler compositions including antioxidants
WO2012171540A1 (en) 2011-06-15 2012-12-20 Bene-Arzneimittel Gmbh Suppository comprising pantoprazole comprised in pellets with a cellulose core
US9707739B2 (en) 2011-07-22 2017-07-18 Baker Hughes Incorporated Intermetallic metallic composite, method of manufacture thereof and articles comprising the same
US9033055B2 (en) 2011-08-17 2015-05-19 Baker Hughes Incorporated Selectively degradable passage restriction and method
US9090956B2 (en) 2011-08-30 2015-07-28 Baker Hughes Incorporated Aluminum alloy powder metal compact
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US8876694B2 (en) 2011-12-07 2014-11-04 Apollo Endosurgery, Inc. Tube connector with a guiding tip
US8961394B2 (en) 2011-12-20 2015-02-24 Apollo Endosurgery, Inc. Self-sealing fluid joint for use with a gastric band
US9010416B2 (en) 2012-01-25 2015-04-21 Baker Hughes Incorporated Tubular anchoring system and a seat for use in the same
US11565027B2 (en) 2012-12-11 2023-01-31 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
KR101766679B1 (en) 2012-12-11 2017-08-09 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 Hydrogel membrane for adhesion prevention
WO2014144364A1 (en) 2013-03-15 2014-09-18 Children's Medical Center Corporation Gas-filled stabilized particles and methods of use
WO2015027087A2 (en) * 2013-08-21 2015-02-26 Children's National Medical Center Dissolvable on-command implant
US9816339B2 (en) 2013-09-03 2017-11-14 Baker Hughes, A Ge Company, Llc Plug reception assembly and method of reducing restriction in a borehole
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
US11167343B2 (en) 2014-02-21 2021-11-09 Terves, Llc Galvanically-active in situ formed particles for controlled rate dissolving tools
US10865465B2 (en) 2017-07-27 2020-12-15 Terves, Llc Degradable metal matrix composite
US10150713B2 (en) 2014-02-21 2018-12-11 Terves, Inc. Fluid activated disintegrating metal system
EP3200838B1 (en) 2014-09-30 2019-09-18 Allergan Industrie, SAS Stable hydrogel compositions including additives
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
CN109890847A (en) * 2016-10-31 2019-06-14 丘比株式会社 Gel combination and its manufacturing method
WO2022271985A1 (en) * 2021-06-24 2022-12-29 Rvo 2.0 Inc, D/B/A Optics Medical Catheters comprising a hydrogel polymer

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2485512A (en) * 1941-10-21 1949-10-18 Alginate Ind Ltd Manufacture of transparent alginic films
GB579004A (en) * 1943-11-12 1946-07-19 Ernest Gordon Greville Improved surgical sutures and like surgical material and the manufacture thereof
GB674755A (en) * 1949-08-04 1952-07-02 Courtaulds Ltd Improvements in and relating to the production of artificial protein fibres
US2712672A (en) * 1952-01-28 1955-07-12 Calcagno Luigi Process for preparing proteic sponges
US2847713A (en) * 1955-05-13 1958-08-19 Weingand Richard Process for producing synthetic sausage skins and other laminar structures from alginates
US2897547A (en) * 1955-05-27 1959-08-04 Weingand Richard Process for producing synthetic sausage casing from alginates or alginic acid
US3271496A (en) * 1964-01-27 1966-09-06 Amicon Corp Method of shaping polyelectrolyte polymer
US4137921A (en) * 1977-06-24 1979-02-06 Ethicon, Inc. Addition copolymers of lactide and glycolide and method of preparation
US4339295A (en) * 1978-12-20 1982-07-13 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Hydrogel adhesives and sandwiches or laminates using microwave energy
US4286341A (en) * 1979-04-16 1981-09-01 Iowa State University Research Foundation, Inc. Vascular prosthesis and method of making the same
JPS5714640A (en) * 1980-07-02 1982-01-25 Toray Ind Inc Separating membrane of methyl methacrylate type
EP0065884B1 (en) * 1981-05-27 1986-08-20 Unitika Ltd. Urethral catheter capable of preventing urinary tract infection and process for producing the same
US4613517A (en) * 1983-04-27 1986-09-23 Becton, Dickinson And Company Heparinization of plasma treated surfaces
CA1238043A (en) * 1983-12-15 1988-06-14 Endre A. Balazs Water insoluble preparations of hyaluronic acid and processes therefor
FR2559666B1 (en) * 1984-02-21 1986-08-08 Tech Cuir Centre PROCESS FOR THE MANUFACTURE OF COLLAGEN TUBES, ESPECIALLY LOW-DIAMETER TUBES, AND APPLICATION OF THE TUBES OBTAINED IN THE FIELD OF VASCULAR PROSTHESES AND NERVOUS SUTURES
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US4650488A (en) * 1984-05-16 1987-03-17 Richards Medical Company Biodegradable prosthetic device
SE442820B (en) * 1984-06-08 1986-02-03 Pharmacia Ab GEL OF THE CROSS-BOND HYALURONIC ACID FOR USE AS A GLASS BODY SUBSTITUTE
US4863907A (en) * 1984-06-29 1989-09-05 Seikagaku Kogyo Co., Ltd. Crosslinked glycosaminoglycans and their use
US4801475A (en) * 1984-08-23 1989-01-31 Gregory Halpern Method of hydrophilic coating of plastics
US4605691A (en) * 1984-12-06 1986-08-12 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5128326A (en) * 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US4636524A (en) * 1984-12-06 1987-01-13 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5202431A (en) * 1985-07-08 1993-04-13 Fidia, S.P.A. Partial esters of hyaluronic acid
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
JPS6233855A (en) * 1985-07-31 1987-02-13 株式会社 君津化学研究所 Alginic acid nonwoven fabric and its production
EP0213908A3 (en) * 1985-08-26 1989-03-22 Hana Biologics, Inc. Transplantable artificial tissue and process
US4997443A (en) * 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
US4902295A (en) * 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
SE8504501D0 (en) * 1985-09-30 1985-09-30 Astra Meditec Ab METHOD OF FORMING AN IMPROVED HYDROPHILIC COATING ON A POLYMER SURFACE
US4838876A (en) * 1986-04-29 1989-06-13 The Kendall Company Silicone rubber catheter having improved surface morphology
IT1198449B (en) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani ESTERS OF POLYVALENT ALCOHOLS OF HYALURONIC ACID
JPH0696023B2 (en) * 1986-11-10 1994-11-30 宇部日東化成株式会社 Artificial blood vessel and method for producing the same
GB8729977D0 (en) * 1987-12-23 1988-02-03 Bard Ltd Catheter
US4888016A (en) * 1988-02-10 1989-12-19 Langerman David W "Spare parts" for use in ophthalmic surgical procedures
US5061738A (en) * 1988-04-18 1991-10-29 Becton, Dickinson And Company Blood compatible, lubricious article and composition and method therefor
IT1219587B (en) * 1988-05-13 1990-05-18 Fidia Farmaceutici SELF-CROSS-LINKED CARBOXYLY POLYSACCHARIDES
US5085629A (en) * 1988-10-06 1992-02-04 Medical Engineering Corporation Biodegradable stent
US5057606A (en) * 1989-01-24 1991-10-15 Minnesota Mining And Manufacturing Company Form-in-place polysaccharide gels
US5089606A (en) * 1989-01-24 1992-02-18 Minnesota Mining And Manufacturing Company Water-insoluble polysaccharide hydrogel foam for medical applications
HU203372B (en) * 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
US5049138A (en) * 1989-11-13 1991-09-17 Boston Scientific Corporation Catheter with dissolvable tip
EP0454373B1 (en) * 1990-04-23 1995-08-23 Monsanto Company Gellan gum fibers
US5077352A (en) * 1990-04-23 1991-12-31 C. R. Bard, Inc. Flexible lubricious organic coatings
US5149543A (en) * 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
JP2777279B2 (en) * 1990-10-08 1998-07-16 工業技術院長 Wound dressing and method for producing the same
IT1247157B (en) * 1991-02-11 1994-12-12 Fidia Spa BIODEGRADABLE AND BIOABSORBABLE GUIDE CHANNELS TO BE USED FOR NERVE REGENERATION.
GR920100122A (en) * 1991-04-05 1993-03-16 Ethicon Inc Ionically crosslinked carboxyl-containing polysaccharides for adhension prevention.
US5334640A (en) * 1992-04-08 1994-08-02 Clover Consolidated, Ltd. Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods
US5306764A (en) * 1992-09-03 1994-04-26 China Technical Consultants Inc. Water dispersible polyurethane and process for preparation thereof
US5531716A (en) * 1993-09-29 1996-07-02 Hercules Incorporated Medical devices subject to triggered disintegration

Also Published As

Publication number Publication date
DE69429227T2 (en) 2002-07-25
US5820608A (en) 1998-10-13
RU2138297C1 (en) 1999-09-27
BR9403911A (en) 1995-05-30
AU7429694A (en) 1995-04-13
AU685152B2 (en) 1998-01-15
PL305241A1 (en) 1995-04-03
DE69429227D1 (en) 2002-01-10
US6126645A (en) 2000-10-03
EP0645150A1 (en) 1995-03-29
ATE209511T1 (en) 2001-12-15
JPH07163655A (en) 1995-06-27
US5531716A (en) 1996-07-02
JP3703155B2 (en) 2005-10-05
US5650116A (en) 1997-07-22
CN1114177A (en) 1996-01-03
US6096018A (en) 2000-08-01
CA2132293C (en) 2009-04-07
RU94034125A (en) 1996-07-10
DK0645150T3 (en) 2002-03-18
EP0645150B1 (en) 2001-11-28
CA2132293A1 (en) 1995-03-30
PL177431B1 (en) 1999-11-30

Similar Documents

Publication Publication Date Title
KR950007801A (en) Medical devices prone to disintegration
DE69725442T2 (en) MEDICAL DEVICES WITH IONIC AND NON-IONICALLY CROSS-LINKED POLYMER HYDROGELS WITH IMPROVED MECHANICAL PROPERTIES
Mittal et al. Recent progress on the design and applications of polysaccharide‐based graft copolymer hydrogels as adsorbents for wastewater purification
CA2261806C (en) Medical devices containing in-situ generated medical compounds
JP4331795B2 (en) Medical device with improved elastic response
Peng et al. Xylan-rich hemicelluloses-graft-acrylic acid ionic hydrogels with rapid responses to pH, salt, and organic solvents
JP6388639B2 (en) NDGA polymer and metal complex thereof
US10875933B2 (en) Hemostatic devices with improved properties and methods of making same
CA2371833A1 (en) Hyaluronic acid gel composition, process for its production and medical material containing it
JP2012082428A (en) Composition of semi-interpenetrating polymer network
JP2004323453A (en) Decomposable gel and method for producing the same
Kam et al. Storage of partially deacetylated chitosan films
Hamidi et al. Antibacterial activity of natural polymer gels and potential applications without synthetic antibiotics
Eid et al. Swelling modelling and kinetics investigation of polymer hydrogel composed of Chitosan-g-(AA-AM)
CN101130105A (en) Wound dressing of povidone iodine hydrogel and radiation preparation method of the same
Zheng et al. Advances in intelligent response and nano-enhanced polysaccharide-based hydrogels: Material properties, response types, action mechanisms, applications
WO2015044455A1 (en) Single-step functionalization and cross-linking of hyaluronic acid
Mahdy et al. Radiation initiated synthesis of (carboxymethyl cellulose/polyacryalmide) hydrogels with polyprotic acid moieties and their utilization in nicotinic acid release
Raj et al. State-of-the-art progress on tamarind seed polysaccharide (Tamarindus indica) and its diverse potential applications, a review with insight
Nootsuwan et al. Preparation of nano‐silver coated poly (vinyl alcohol) via a heterogeneous coating system for various antimicrobial products
CN117356563A (en) Modified starch acidic hydrogel chlorine dioxide slow-release air disinfectant and preparation method thereof
SU936512A1 (en) Method of blood coagulation prevention
Singh et al. Chitosan-Based Hydrogels-Synthesis, Characterization and Swelling Behaviour
DE102015013680A1 (en) Electrostrictive generative manufacturing of physical objects

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E601 Decision to refuse application